Edgewise Therapeutics (EWTX) PT Raised to $32 at Goldman Sachs

June 17, 2026 5:30 AM

Goldman Sachs analyst Paul Choi raised the price target on Edgewise Therapeutics (NASDAQ: EWTX) to $32.00 while maintaining a Neutral ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found